Dabur India reported robust fourth-quarter earnings growth driven by strong domestic FMCG demand, healthy volume expansion and broad-based ...

Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...

In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...

To be eligible, loans must be extended to individuals or small businesses with turnover up to ?500 crore, fall under standard retail produc...

Reliance Industries anticipates a subdued earnings report this quarter. The oil-to-chemicals segment faces pressure, impacting overall numb...

Reckitt's India operations achieved double-digit growth in the first quarter of 2026. Key brands such as Dettol and Durex performed strongl...

Indian enterprises are navigating challenges posed by the Goods and Services Tax. The inverted duty scenario is particularly affecting FMCG...

Dr Reddy's Laboratories said the combined market of Prilosec OTC and private label omeprazole OTC products had US retail sales of around $4...

Softovac's shift to OTC was piloted in West Bengal during which the brand witnessed a growth in sales of over 25 per cent, and post the suc...

The Mumbai-based company is on an acquisition spree and has snapped key brands from global rivals Pfizer and MSD in the last one year for a...

Morepen has mandated Deloitte Touche Tohmatsu to run a formal process and the negotiations are at quite an advanced stage.

The group is looking to rope in a financial partner to play up its inorganic strategy of acquiring small OTC brands and businesses, said so...

Novartis's board approved sale of its OTC division to GSK Consumer Pvt Ltd, a consumer healthcare JV between Novartis AG & GSK, for a consi...

According to top executives from both the companies, Ranbaxy's OTC portfolio is going to be one of the key segments for Sun Pharma with sig...

JBCPL said it has completed Rs 939 crore deal to sell its over-the-counter business in Russia & CIS nations to Johnson & Johnson arm Cilag ...

Building global brands and also looking at those, which have intellectual property are of top priority, says Swati Piramal, Director-Strate...

The acquisition of Pfizer’s global over-the-counter (OTC) business by Johnson & Johnson (J&J) will have some impact on Pfizer India, though...